🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a non-comparative open-label multicenter Phase 2 clinical trial com...
Status
Completed
Location
University of California San Francisco
Start Date
2017-05-17
Trial ID
NCT03007732
Multicenter Phase II Study of Axitinib +/- Pembrolizumab in First Line Trea...
Status
Unknown
Location
Ico - Paul Papin
Start Date
2022-06-01
Trial ID
NCT05096390
Treatments Being Tested
This is a phase 2 trial investigating the effect and safety of pembrolizuma...
Status
Unknown
Location
Beijing Cancer Hospital & Institute
Start Date
2022-12-01
Trial ID
NCT05386056
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-05-30
Trial ID
NCT05824975
This trial proposes to evaluate the immunologic and potential clinical effe...
Status
Not Yet Recruiting
Location
UMPC Hillman Cancer Center
Start Date
2026-08
Trial ID
NCT07634094
Treatments Being Tested
This research is studying the safety and effectiveness of AMD3100 and pembr...
Status
Withdrawn
Location
Massachusetts General Hospital Cancer Center
Start Date
2019-09-30
Trial ID
NCT04058145
Treatments Being Tested
The goal of the Phase 1 study was to find the recommended Phase 2 dose of t...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2015-12
Trial ID
NCT02644967
Treatments Being Tested
This is a prospective, single-arm, open clinical study, which was designed ...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2023-11-30
Trial ID
NCT06132698
Treatments Being Tested
To study the safety and clinical effect of injection of drug-eluting micros...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2020-11-01
Trial ID
NCT04770207
Treatments Being Tested
PDC-LUNG-101 trial is an open-label, dose-escalation, phase I/II study to a...
Status
Active Not Recruiting
Location
Grand Hôpital de Charleroi
Start Date
2019-09-10
Trial ID
NCT03970746
Treatments Being Tested